![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/spyre-therapeutics-announces-first-participants-dosed-in-phase-1-trial-of-spy001-its-novel-half-life-extended-anti-47-antibody-for-the-treatment-of-inflammatory-bowel-disease-302174975.html
https://www.prnewswire.com/news-releases/spyre-therapeutics-reports-first-quarter-2024-financial-results-and-provides-corporate-update-302141080.html
https://endpts.com/apogee-spyre-founder-launches-its-third-biotech-and-heads-straight-to-nasdaq/
https://ir.spyre.com/2024-03-18-Spyre-Therapeutics-Announces-180-Million-Private-Placement
https://ir.spyre.com/2024-03-01-Spyre-Therapeutics-Announces-Grants-of-Inducement-Awards